Kayne Anderson Rudnick Investment Management
AMED

Kayne Anderson Rudnick Investment Management’s Amedisys AMED Stock Holding History

Kayne Anderson Rudnick Investment Management’s Portfolio AMED Stock Details AMED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-247
Closed -$18.2K – 884
2023
Q1 		$18.2K Hold
247
– – ﹤0.01% 548
2022
Q4 		$20.6K Buy
+247
New +$22.3K ﹤0.01% 558
2021
Q1 		– Sell
-3
Closed -$1K – 566
2020
Q4 		$1K Buy
+3
New +$769 ﹤0.01% 568

Other funds holding AMED

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
RP
Riverbridge Partners Minneapolis, Minnesota $3.58B AUM 4.02% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Mackenzie Financial
Mackenzie Financial Toronto Ontario, Ontario, Canada $83.3B AUM 31.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
AAM
Alpine Associates Management Palm Beach, Florida $1.6B AUM 93.19% 1-Year Est. Return

Kayne Anderson Rudnick Investment Management's AMED Position: Q2 2023 in Review

Kayne Anderson Rudnick Investment Management sold out of Amedisys (AMED) in Q2 2023, closing a stake of 247 shares — an estimated $18.2K sold.

Kayne Anderson Rudnick Investment Management first reported a position in AMED in Q4 2020 and held it in 3 quarters. The position peaked at $20.6K in Q4 2022. 302 funds tracked by Wall St. Rank hold AMED as of Q2 2023.

  • Kayne Anderson Rudnick Investment Management reported no remaining Amedisys position as of Q2 2023 after selling out during the quarter.
  • Kayne Anderson Rudnick Investment Management sold 247 Amedisys shares in Q2 2023, an estimated $18.2K.
  • Kayne Anderson Rudnick Investment Management first reported a position in Amedisys in Q4 2020 and held it in 3 quarters.
  • Kayne Anderson Rudnick Investment Management's Amedisys position peaked at $20.6K in Q4 2022.
  • 302 funds tracked by Wall St. Rank held Amedisys as of Q2 2023.

Based on Kayne Anderson Rudnick Investment Management's 13F filing for Q2 2023, filed 11 Aug 2023.